Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency

por Cohen-Barak, Orit, Sakov, Anat, Rasamoelisolo, Michele, Bassan, Merav, Brown, Kurt, Mendzelevski, Boaz, Spiegelstein, Ofer
Publicado 2015

Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase II studies

por Alavi, Afsaneh, Hamzavi, Iltefat, Brown, Kurt, Santos, Leandro L., Zhu, Zhaoyin, Liu, Huiqing, Howell, Michael D., Kirby, Joslyn S.
Publicado 2022

A phase II study of laquinimod in Crohn's disease

por D'Haens, Geert, Sandborn, William J, Colombel, Jean Frederic, Rutgeerts, Paul, Brown, Kurt, Barkay, Hadas, Sakov, Anat, Haviv, Asi, Feagan, Brian G
Publicado 2015

A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis

por Schmidt, Wolfgang A., Dasgupta, Bhaskar, Luqmani, Raashid, Unizony, Sebastian H., Blockmans, Daniel, Lai, Zhihong, Kurrasch, Regina H., Lazic, Ivana, Brown, Kurt, Rao, Ravi
Publicado 2020

Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE)

por Aletaha, Daniel, Bingham, Clifton O, Karpouzas, George Athanasios, Takeuchi, Tsutomu, Thorne, Carter, Bili, Androniki, Agarwal, Prasheen, Hsu, Benjamin, Rao, Ravi, Brown, Kurt, Tanaka, Yoshiya
Publicado 2021

A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis

por Weisel, Kathy, Scott, Nicola, Berger, Scott, Wang, Susanne, Brown, Kurt, Powell, Marcy, Broer, Matthijs, Watts, Clarissa, Tompson, Debra J, Burriss, Susan W, Hawkins, Simon, Abbott-Banner, Kathy, Tak, Paul Peter
Publicado 2021